Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    22056247 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus
Conditions: Renal Cell Carcinoma;   Nonclear Cell;   Temsirolimus Resistance
Intervention: Drug: Axitinib
2 Recruiting Tolerability and Pharmacokinetics of JS001 in Combination With Axitinib in Patients With Kidney Cancer and Melanoma
Conditions: Kidney Cancer Stage Iv;   Advanced Melanoma
Intervention: Biological: humanized anti-PD-1 monoclonal antibody
3 Completed
Has Results
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Condition: Kidney Neoplasms
Interventions: Drug: Axitinib (AG-013736);   Drug: Sorafenib

Study has passed its completion date and status has not been verified in more than two years.